AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
175.26
+0.45 (0.26%)
Jan 29, 2025, 4:00 PM EST - Market closed
AbbVie Analyst Ratings
Total Analysts
21
Consensus Rating
Strong Buy
Price Target
$206.75
Upside
+17.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $215 → $205 | Strong Buy | Maintains | $215 → $205 | +16.97% | Jan 28, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $215 → $211 | Strong Buy | Maintains | $215 → $211 | +20.39% | Jan 8, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $212 → $220 | Buy | Maintains | $212 → $220 | +25.53% | Dec 17, 2024 |
| B of A Securities | B of A Securities | Hold Initiates $191 | Hold | Initiates | $191 | +8.98% | Dec 10, 2024 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $206 | Hold → Buy | Upgrades | $206 | +17.54% | Nov 22, 2024 |
| Wolfe Research | Wolfe Research | Buy Initiates $205 | Buy | Initiates | $205 | +16.97% | Nov 15, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $210 → $200 | Buy | Maintains | $210 → $200 | +14.12% | Nov 13, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $226 → $215 | Strong Buy | Maintains | $226 → $215 | +22.67% | Nov 12, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $228 → $208 | Buy | Maintains | $228 → $208 | +18.68% | Nov 12, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $231 → $224 | Buy | Maintains | $231 → $224 | +27.81% | Nov 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $212 → $221 | Strong Buy | Maintains | $212 → $221 | +26.10% | Nov 6, 2024 |
| Argus Research | Argus Research | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Nov 4, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $220 → $228 | Buy | Maintains | $220 → $228 | +30.09% | Oct 31, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $215 → $226 | Strong Buy | Maintains | $215 → $226 | +28.95% | Oct 31, 2024 |
| UBS | UBS | Hold Maintains $195 → $200 | Hold | Maintains | $195 → $200 | +14.12% | Oct 31, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $218 → $231 | Buy | Maintains | $218 → $231 | +31.80% | Oct 31, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.